Skip to content
  • Sunday, 26 July 2026
  • 3:38 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Evosep Unveils Evosep Proteomics: A Standardized Ecosystem for Scaling LC-MS-Based Proteomics in Research and Drug Development
Biotech & Genetic Research

Evosep Unveils Evosep Proteomics: A Standardized Ecosystem for Scaling LC-MS-Based Proteomics in Research and Drug Development

Jia Lissa Jun 4, 2026 0

Odense, Denmark – Evosep, a leading innovator in liquid chromatography solutions, has announced the launch of Evosep Proteomics, a comprehensive…

Read More
Pharmaceutical R&D

Scaling GLP-1 Obesity Trials Without Losing DXA Data

Teuku Ryan May 29, 2026 0

The explosive growth of global obesity trials, fueled by the success of GLP-1 receptor agonist therapies, presents a critical challenge:…

Read More
Pharmaceutical R&D

AI Governance and Trust: The Bedrock for Scaling Innovation in Drug Development

Teuku Ryan Apr 24, 2026 0

The accelerating adoption of artificial intelligence (AI) within the pharmaceutical industry is not merely a technological advancement; it is a…

Read More
McGill Researchers Identify Specific Brain Cells Linked to Major Depressive Disorder Through Advanced Genomic MappingScience News: Empowering Public Understanding of Science, Medicine, and Technology Since 1921Paternal Age and Genetic Risk: New Research Reveals How Natural Selection in Sperm Favors Disease-Causing MutationsBlazing new paths for biotech
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ